Literature DB >> 20837500

Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease.

Der-Yuan Chen1, Yi-Ming Chen, Joung-Liang Lan, Chi-Chen Lin, Hsin-Hua Chen, Chia-Wei Hsieh.   

Abstract

OBJECTIVE: To investigate the potential role of Th type 17 (Th17) cells and Th17-related cytokines in the pathogenesis of adult-onset Still's disease (AOSD).
METHODS: The frequencies of circulating Th17 cells in 24 patients with active untreated AOSD, 16 patients with active SLE and 12 healthy volunteers were determined using intracellular cytokine staining and flow cytometry. Serum levels of Th17-related cytokines, including IL-1β, IL-6, IL-17, IL-18, IL-21 and IL-23 were measured by ELISA.
RESULTS: Significantly higher median frequencies of circulating Th17 cells were found in active untreated AOSD patients (1.01%) and active SLE patients (1.26%) than in healthy volunteers (0.12%, both P<0.001). The frequencies of circulating Th17 cells were positively correlated with activity score (r=0.527, P<0.01) and serum ferritin levels (r=0.724, P<0.001) in AOSD patients, and correlated with SLEDAI (r=0.663, P<0.01) in SLE patients. Additionally, the frequencies of circulating Th17 cells were positively and significantly correlated with serum levels of IL-1β, IL-6, IL-17, IL-18, IL-21 and IL-23 in both AOSD and SLE patients. The frequencies of circulating Th17 cells and serum IL-17 levels significantly decreased after effective therapy in AOSD patients (both P<0.001).
CONCLUSION: Elevated frequencies of circulating Th17 cells and a positive correlation with disease activity in our AOSD patients suggest that Th17 cells contribute to the pathogenesis of this disease. Dysregulation of Th17 cells may be a common pathogenic mechanism that underlies the development of both AOSD and SLE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837500     DOI: 10.1093/rheumatology/keq284

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  25 in total

Review 1.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 2.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

3.  Does searching for antineutrophil cytoplasmic antibodies help with the diagnosis of Adult-onset Still's disease?

Authors:  Massoud Saghafi; Maryam Sahebari
Journal:  Rheumatol Int       Date:  2012-03-31       Impact factor: 2.631

4.  Th17 response and inflammatory autoimmune diseases.

Authors:  Janelle C Waite; Dimitris Skokos
Journal:  Int J Inflam       Date:  2011-11-15

5.  Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.

Authors:  Yasuhiro Shimojima; Takanori Ichikawa; Dai Kishida; Ryota Takamatsu; Yoshiki Sekijima
Journal:  Clin Exp Immunol       Date:  2021-08-12       Impact factor: 4.330

Review 6.  An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.

Authors:  Po-Ku Chen; Der-Yuan Chen
Journal:  J Immunol Res       Date:  2021-06-20       Impact factor: 4.818

7.  Germinal center kinase-like kinase (GLK/MAP4K3) expression is increased in adult-onset Still's disease and may act as an activity marker.

Authors:  Der-Yuan Chen; Huai-Chia Chuang; Joung-Liang Lan; Yi-Ming Chen; Wei-Ting Hung; Kuo-Lung Lai; Tse-Hua Tan
Journal:  BMC Med       Date:  2012-08-06       Impact factor: 8.775

8.  Adult Onset Still's Disease and Autoinflammation.

Authors:  Petros Efthimiou; L Nandini Moorthy; Clio P Mavragani; Dimitris Skokos; Bruno Fautrel
Journal:  Int J Inflam       Date:  2012-08-29

9.  Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.

Authors:  Der-Yuan Chen; Chi-Chen Lin; Yi-Ming Chen; Joung-Liang Lan; Wei-Ting Hung; Hsin-Hua Chen; Kuo-Lung Lai; Chia-Wei Hsieh
Journal:  Arthritis Res Ther       Date:  2013-03-04       Impact factor: 5.156

10.  Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

Authors:  Clio P Mavragani; Evangelos G Spyridakis; Michael Koutsilieris
Journal:  Int J Inflam       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.